FRBRX Mutual Fund

NAV$204.19

AUM$6M

TER0.67%

Holdings120

See how much of FRBRX you already own

Just $25 once·$99/mo·Download sample

X-ray my portfolio free

FRBRX Mutual Fund

NAV$204.19

Franklin Biotechnology Discovery Fund Class R6

AUM$6M

TER0.67%

Holdings120

See how much of FRBRX you already own

Just $25 once·$99/mo·Download sample

X-ray my portfolio free

Overview Performance Chart Dividends Top Holdings All Holdings Sectors Geography Similar Compare Overlap

Showing top 50 of 112 holdings · as of Jul 31, 2026

FRBRX holdings, by weight
#	Ticker	Name	Weight	Cumulative	Shares	Mkt value	Sector	Industry
1	JAZZ	Jazz Pharmaceuticals Plc.Health Care · Pharmaceuticals	5.66%	5.7%	258,371	$65.33M	Health Care	Pharmaceuticals
2	AMGN	Amgen Inc.Health Care · Pharmaceuticals	4.39%	10.1%	131,554	$50.67M	Health Care	Pharmaceuticals
Sector and industry · Pro
3	GILD	Gilead Sciences	3.86%	13.9%	341,817	$44.51M
4	REGN	Regeneron Pharmaceuticals, Inc.	3.77%	17.7%	57,013	$43.48M
5	—	Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)	3.62%	21.3%	48,962	$41.80M
6	VRTX	Vertex Pharmaceuticals Inc	3.54%	24.8%	85,620	$40.85M
7	RVMD	Revolution Medicines Inc	3.01%	27.9%	185,428	$34.77M
8	GH	Guardant Health, Inc	2.76%	30.6%	196,520	$31.83M
9	—	Ascendis Pharma A/S	2.56%	33.2%	121,287	$29.58M
10	ORKA	Oruka Therapeutics Inc Orka	2.48%	35.6%	296,262	$28.59M
11	DNTH	Dianthus Therapeutics Inc	2.32%	38.0%	250,308	$26.76M
12	SYRE	Spyre Therapeutics Inc	2.09%	40.1%	245,009	$24.09M
13	INSM	Insmed Inc	1.99%	42.1%	233,052	$22.98M
14	MIRM	Mirum Pharmaceuticals, Inc.	1.98%	44.0%	215,190	$22.80M
15	PRAX	Praxis Precision Medicines Inc	1.91%	45.9%	71,799	$22.10M
16	NBIX	Neurocrine Biosciences Inc	1.82%	47.8%	125,643	$20.96M
17	BBIO	Bridgebio Pharma Inc	1.67%	49.4%	241,119	$19.31M
18	PTCT	Ptc Therapeutics Inc	1.65%	51.1%	279,737	$19.02M
19	—	AstraZeneca PLC	1.51%	52.6%	102,531	$17.39M
20	INFXX	Ift - Money Market Port	1.45%	54.0%	16,697,193	$16.70M
21	AMLX	Amylyx Pharmaceuticals Inc	1.32%	55.4%	752,824	$15.29M
22	LLY	Eli Lilly & Co	1.31%	56.7%	13,131	$15.09M
23	CYTK	Cytokinetics Inc	1.24%	57.9%	186,018	$14.35M
24	TNGX	Tango Therapeutics Inc.	1.23%	59.1%	521,761	$14.18M
25	EYPT	Eyepoint Pharmaceuticals Inc.(eypt)	1.19%	60.3%	1,123,495	$13.76M
26	ABVX	Abivax Sa-Adr	1.18%	61.5%	109,022	$13.62M
27	ARQT	Arcutis Biotherapeutics Inc	1.18%	62.7%	505,651	$13.58M
28	MLYS	Mineralys Therapeutics Inc	1.18%	63.9%	533,511	$13.62M
29	—	Indivior Pharmaceuticals, Inc. Ordinary Shares	1.15%	65.0%	332,496	$13.30M
30	—	Thermo Fisher	1.14%	66.2%	22,999	$13.21M
31	DYN	Dyne Therapeutics Inc	1.13%	67.3%	519,232	$13.07M
32	BCAX	Bicara Therapeutics, Inc.	1.11%	68.4%	474,899	$12.87M
33	CGON	Cg Oncology Inc	1.08%	69.5%	174,532	$12.42M
34	BNTC	Benitec Biopharma Inc.	1.01%	70.5%	995,152	$11.65M
35	—	Alkermes Plc. Ordinary Shares	0.99%	71.5%	232,937	$11.41M
36	SLDB	Solid Biosciences Inc	0.98%	72.5%	1,409,093	$11.36M
37	SNDX	Syndax Pharmaceuticals Inc	0.96%	73.4%	582,815	$11.10M
38	IONS	Ionis Pharmaceuticals Inc	0.94%	74.4%	209,423	$10.84M
39	BGNE	BeOne Medicines Ltd. Sponsored Adr (1 Ads : 13 Ordinary)	0.92%	75.3%	33,421	$10.56M
40	ALNY	Alnylam Pharmaceuticals Inc.	0.91%	76.2%	51,286	$10.54M
41	CTNM	Contineum Therapeutics, Inc.	0.84%	77.0%	625,148	$9.68M
42	JBIO	Jade Biosciences Inc	0.82%	77.8%	479,949	$9.48M
43	ANRO	Alto Neuroscience, Inc., Series C	0.82%	78.7%	347,904	$9.42M
44	PCVX	Vaxcyte Inc	0.68%	79.3%	145,674	$7.88M
45	—	Xenon Pharmaceuticals Inc	0.67%	80.0%	123,767	$7.76M
46	RLAY	Relay Therapeutics Inc	0.66%	80.7%	404,940	$7.63M
47	ORIC	ORIC Pharmaceuticals, Inc.	0.63%	81.3%	659,005	$7.30M
48	NGNE	NEURogene	0.62%	81.9%	218,783	$7.20M
49	ACHV	Achieve Life Sciences Inc	0.61%	82.5%	1,095,791	$7.03M
50	—	Biontech Se Adr	0.58%	83.1%	73,400	$6.65M
More holdings · Pro

Not reported for this fund: share changes.

FundXLS Pro

See the other 62 holdings of FRBRX

X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.

Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

FRBRX Mutual Fund All Holdings

FRBRX holdings total 120 positions. The top 10 holdings account for 35.6% of the fund, led by Jazz Pharmaceuticals Plc. at 5.7%, Amgen Inc. at 4.4%, Gilead Sciences at 3.9%.

FRBRX portfolio concentration is moderate, with the top 10 representing 35.6% of total assets. The largest sector exposure is Health Care at 85.0%.

FRBRX sectors provide a detailed breakdown. FRBRX overlap shows how holdings compare to other funds in your portfolio.